Drs. Liu, Lim, and Lee are listed as coinventors on the application.
Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair†
Version of Record online: 31 AUG 2011
Copyright © 2011 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 63, Issue 9, pages 2711–2720, September 2011
How to Cite
Liu, T. M., Guo, X. M., Tan, H. S., Hui, J. H., Lim, B. and Lee, E. H. (2011), Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair. Arthritis & Rheumatism, 63: 2711–2720. doi: 10.1002/art.30430
A PCT (international) patent application has been submitted by Genome Institute of Singapore for the use of transcription factor ZNF145 for the repair and regeneration of cartilage.
- Issue online: 31 AUG 2011
- Version of Record online: 31 AUG 2011
- Accepted manuscript online: 5 MAY 2011 10:33AM EST
- Manuscript Accepted: 26 APR 2011
- Manuscript Received: 24 JAN 2011
- Biomedical Research Council, Singapore. Grant Number: BMRC grant R-175-000-085-305
- Singapore Stem Cell Consortium, Singapore. Grant Number: SSCC-006-008
- Agency for Science, Technology, and Research (A*STAR), Singapore
- NIH. Grant Numbers: DK-047636, AI-54973
- 24Treatment of chondral lesions in advanced osteochondritis dissecans: a comparative study of the efficacy of chondrocytes, mesenchymal stem cells, periosteal graft and mosaicplasty (osteochondral autograft) in animal models. J Pediatr Orthop 2004; 24: 427–33., , , .